from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2130c/mshC

LFCtreatmentdescriptionclass of inhibitor

-0.301

Amikacinug/mL Amikacintranslation

0.050

Cap5-10ug/mL Capreomycintranslation

0.242

Rox10-50 ug/mL Roxithromycintranslation

0.628

SM2-5 ug/mL Streptomycintranslation

1.109

Tet5-10 ug/mL Tetracyclinetranslation

-0.639

Rif0.2-5ug/mL Rifampicintranscription

-1.223

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.405

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.558

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.871

CPZ10-50 ug/mL Chlorpromazinerespiration

0.588

Clofazimine10-13 ug/mL Clofaziminerespiration

0.190

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.906

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.327

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.435

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.228

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.184

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.578

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.370

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.008

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.635

KCN5-20 ug/mL Potassium cyaniderespiration

-0.118

NaN30.2-2 mM Sodium aziderespiration

0.150

Nigericin50 uM Nigericinrespiration

-0.009

TRC10-150 ug/mL Triclosanrespiration

0.915

TRZ10-25 ug/mL Thioridazinerespiration

-0.911

Valinomycin0.5-10 uM Valinomycinrespiration

0.509

ZnSO42 mM ZnSO4respiration

0.447

menadione6-10 ug/mL Menadionerespiration

0.407

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.207

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.092

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.345

NRP_1Non-replicating persistence stage 1dosRassociated

0.467

Amp0.2mg/mL AmpicillincellWall

0.107

Cephalexin20-100 ug/mL CephalexincellWall

0.103

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.025

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.326

EMB10-20 ug/mL EthambutolcellWall

0.596

Eta12-40 ug/mL EthionamidecellWall

0.615

INH0.2-0.4 ug/mL IsoniazidcellWall

0.273

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.063

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.141

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.544

BZA0.12 mg/mL BenzamidearomaticAmides

-1.195

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.052

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.533

H2O24 mM hydrogen peroxideDNAdamaging

-0.079

Levo10 ug/mL LevofloxacinDNAdamaging

-0.341

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.876

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.299

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.143

UVUV-irradiationDNAdamaging

0.910

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.128

Antimycin12.5-50 ug/mL Antimycin A?

0.025

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.170

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.235

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.207

PA8240.2-2 ug/mL PA-824?

0.506

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.497

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.080

Verapamil50 uM Verapamil?

0.679

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.296

methoxatin10-20 ug/mL Methoxatin?